Dr. Louis Cappelli

Dr. Louis Cappelli

Chief Resident
Thomas Jefferson University Hospital Radiation Oncology Department

Residency
Radiation Oncology, Thomas Jefferson University Hospital
Internship – Internal Medicine, Inspira Health Network – 2021

Understanding the Treatment Path for Glioma Patients

Molecular Testing for IDH Inhibitors in Glioma Patients

New FDA Approved Vorasidenib for IDH Mutant Gliomas

Targeting Gene Mutations in Gliomas with IDH Inhibitors

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider